Nanjing Pharmaceutical Co. Ltd.

Pharmaceuticals
China
Executive 1Teng Xuewu, Executive Vice President; Vice-president | Executive Vice President; Vice-president
Executive 2Zhou Jianjun, Chief Sales Officer; President | Executive Vice President;
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$3,341
Current Liabilities (US$ Millions)$1,398
Total Assets (US$ Millions)$1,628
Long Term Debt (Millions)N/A
Return on Equity15.02%
Revenue (US$ Millions)$3,568
Total Company Assets$1,831
Revenue Growth (%)17.71%
Net Income (US$ Millions)$25
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$345
Profit Margin (%)0.69%
Debt To Equity Ratio (%)N/A
Inventories (Millions)$277